1st Quarter - Report

KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC

Firm
Client
Income
—
Expenses
$2,990,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822, Break Up Big Medicine Act

LobbyistCovered position, as disclosed
DAVID C BENNETT —
BRENDAN DEVINE New —
MARY PRUDENCE FITZPATRICK —
MARK HAYES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 7148 (119th), S. 4027 (119th), H.R. 6248 (119th), S. 3822 (119th)

Medicare/Medicaid MMM

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. Issues related to Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4208-F3/CMS-4212-F) and 2027 Medicare Advantage and Part D Advance Notice. S. 1105, No UPCODE Act

LobbyistCovered position, as disclosed
DAVID C BENNETT —
BRENDAN DEVINE New —
MARY PRUDENCE FITZPATRICK —
MARK HAYES —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1105 (119th)

Pharmacy PHA

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) H. R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act)

LobbyistCovered position, as disclosed
DAVID C BENNETT —
BRENDAN DEVINE New —
MARY PRUDENCE FITZPATRICK —
MARK HAYES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 2620 (119th), H.R. 3269 (119th), S. 2780 (119th), S. 1954 (119th), H.R. 5429 (119th), S. 1414 (119th), H.R. 5526 (119th)

Budget/Appropriations BUD

Legislation and regulation related to funding, budget and appropriations. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75)

LobbyistCovered position, as disclosed
DAVID C BENNETT —
BRENDAN DEVINE New —
MARY PRUDENCE FITZPATRICK —
MARK HAYES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7148 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.